Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-23T15:00:06.828Z Has data issue: false hasContentIssue false
  • English
  • Français

Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report

Part of: Metabolic

Published online by Cambridge University Press:  16 February 2021

Kentaro Kogawa Open the ORCID record for Kentaro Kogawa [Opens in a new window] ,
Tatsuya Ando  and
Masako Fujiwara
Kentaro Kogawa*
Affiliation:
Department of Paediatrics, The Jikei University School of Medicine, Tokyo, Japan
Tatsuya Ando
Affiliation:
Department of Paediatrics, The Jikei University School of Medicine, Tokyo, Japan
Masako Fujiwara
Affiliation:
Department of Paediatrics, The Jikei University School of Medicine, Tokyo, Japan Department of Paediatrics, Machida Municipal Hospital, Tokyo, Japan
*
Author for correspondence: Kentaro Kogawa, MD, Department of Paediatrics, Jikei University School of Medicine 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan, 105-8461. Tel: 81-(0)3-3433-1111; Fax: 81-(0)3-3435-8665. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Gastrointestinal bleeding complicated with protein-losing enteropathy after the Fontan procedure has been often reported in recent years, but there is no established therapy for it.

We report the case of an 18-year-old boy who suffered from abdominal pain, melena, and anaemia due to intractable haemorrhagic protein-losing enteropathy after the Fontan procedure. He was successfully treated with octreotide therapy.

Keywords

The Fontan procedureprotein-losing enteropathygastrointestinal bleedingoctreotideintramuscular injection
Type
Brief Report
Information
Cardiology in the Young , Volume 31 , Issue 8 , August 2021 , pp. 1333 - 1335
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

John, AS, Johnson, JA, Khan, M, Driscoll, DJ, Warnes, CA, Cetta, F Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 2014; 64: 54–62.CrossRefGoogle ScholarPubMed
Vyas, H, Driscoll, DJ, Cetta, F, Loftus, CG, Connolly, HM Gastrointestinal bleeding and protein-losing enteropathy after the Fontan operation. Am J Cardiol 2006; 98: 666–667.CrossRefGoogle ScholarPubMed
Seewoodhary, J Gastrointestinal haemorrhage in protein-losing enteropathy associated with the Fontan circulation. QJM 2010; 103: 347–349.CrossRefGoogle ScholarPubMed
Gras, P, Gottrand, F, Godart, F Gastrointestinal haemorrhage due to lymphangiectasia caused by protein-losing enteropathy in the Fontan circulation. Cardiol Young 2017; 27: 1641–1643.CrossRefGoogle ScholarPubMed
Lambrecht, L, Cools, B, Witters, P A rare cause of persisting anaemia in a patient with a failing Fontan circulation. Cardiol Young 2017; 27: 176–177.CrossRefGoogle Scholar
Szilagyi, A, Ghali, MP Pharmacological therapy of vascular malformations of the gastrointestinal tract. Can J Gastroenterol 2006; 20: 171–178.CrossRefGoogle ScholarPubMed
John, AS, Phillips, SD, Driscoll, DJ, Warnes, CA, Cetta, F The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation. Congenit Heart Dis 2011; 6: 653–656.CrossRefGoogle ScholarPubMed
Molina, TL, Krisl, JC, Donahue, KR, Varnado, S Gastrointestinal bleeding in left ventricular assist device: octreotide and other treatment modalities. ASAIO J 2018; 64: 433–439.CrossRefGoogle ScholarPubMed
Bornschein, J, Drozdov, I, Malfertheiner, P Octreotide LAR: safety and tolerability issues. Expert Opin Drug Saf 2009; 8: 755–768.CrossRefGoogle ScholarPubMed
Klímová, K, Padilla-Suárez, C, Giménez-Manzorro, A, Pajares-Díaz, JA, Clemente-Ricote, G, Hernando-Alonso, A Octreotide long-active release in the treatment of gastrointestinal bleeding due to vascular malformations: cost-effectiveness study. Rev Esp Enferm Dig 2015; 107: 79–88.Google ScholarPubMed